Tacrolimus depresses local immune cell infiltration but fails to reduce cortical contusion volume in brain-injured rats

被引:20
作者
Thomale, Ulrich W. [1 ]
Bender, Marcel
Casalis, Pablo
Rupprecht, Stefan
Griebenow, Martin
Neumann, Konrad
Woiciechowsky, Christian
Unterberg, Andreas W.
Stover, John F.
机构
[1] Med Univ Berlin, Dept Neurosurg, Campus Virchow Med Ctr, D-13353 Berlin, Germany
[2] Charite, Dept Biometry & Clin Epidemiol, D-10117 Berlin, Germany
[3] Heidelberg Univ, Dept Neurosurg, D-69120 Heidelberg, Germany
[4] Univ Zurich Hosp, Div Surg Intens Care Med, CH-8091 Zurich, Switzerland
关键词
traumatic brain injury; ICAM-1; microglia; macrophages; granulocytes;
D O I
10.1016/j.imbio.2007.01.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The immunosuppressant drug tacrolimus (FK-506) failed to show an anti-edematous effect despite suppressing pro-inflammatory cytokines in cerebrospinal fluid following focal traumatic brain injury. By questioning the role of the inflammatory response as a pharmacological target, we investigated the effects of FK-506 on immune cell infiltration in brain-injured rats. Following induction of a cortical contusion, male Sprague-Dawley rats received FK-506 or physiological saline intraperitoneally. Brains were removed at 24 h, 72 h or 7 days, respectively. Frozen brain sections (7 mu m) were stained immunohistologically for markers of endothelial activation (intercellular adhesion molecule-1-ICAM-1), neutrophil infiltration (His-48), and microglial and macrophage activation (Ox-6; ED-1), respectively. Immunopositive cells were counted microscopically. Contusion volume (CV) was quantified morphometrically 7 days after trauma. Inflammatory response was confined to the ipsilateral cortex and hippocampal formation, predominating in the contusion and pericontusional cortex. Strongest ICAM-1 expression coincided with sustained granulocyte accumulation at 72 h which was suppressed by FK-506. Ox-6 + cells prevailing at 72 h were also significantly reduced by FK-506. ED-1 + cells reaching highest intensity at 7 days were significantly attenuated at 72 h. Cortical CV was not influenced. FK-506 significantly decreased post-traumatic local inflammation which, however, was not associated with a reduction in cortical CV. These results question the importance of post-traumatic local immune cell infiltration in the secondary growth of a cortical contusion. (c) 2007 Elsevier GmbH. All rights reserved.
引用
收藏
页码:567 / 576
页数:10
相关论文
共 52 条
[11]   IMMUNOSUPPRESSANT FK506 ENHANCES PHOSPHORYLATION OF NITRIC-OXIDE SYNTHASE AND PROTECTS AGAINST GLUTAMATE NEUROTOXICITY [J].
DAWSON, TM ;
STEINER, JP ;
DAWSON, VL ;
DINERMAN, JL ;
UHL, GR ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (21) :9808-9812
[12]   Activated/effector CD4+ cells exacerbate acute damage in the central nervous system following traumatic injury [J].
Fee, D ;
Crumbaugh, A ;
Jacques, T ;
Herdrich, B ;
Sewell, D ;
Auerbach, D ;
Piaskowski, S ;
Hart, MN ;
Sandor, M ;
Fabry, Z .
JOURNAL OF NEUROIMMUNOLOGY, 2003, 136 (1-2) :54-66
[13]   Inflammatory gene expression in cerebral ischemia and trauma - Potential new therapeutic targets [J].
Feuerstein, GZ ;
Wang, XK ;
Barone, FC .
NEUROPROTECTIVE AGENTS - THIRD INTERNATIONAL CONFERENCE, 1997, 825 :179-193
[14]   Multiple modes of action of tacrolimus (FK506) for neuroprotective action on ischemic damage after transient focal, cerebral ischemia in rats [J].
Furuichi, Y ;
Noto, T ;
Li, JY ;
Oku, T ;
Ishiye, M ;
Moriguchi, A ;
Aramori, I ;
Matsuoka, N ;
Mutoh, S ;
Yanagihara, T .
BRAIN RESEARCH, 2004, 1014 (1-2) :120-130
[15]   Tacrolimus (FK506) down-regulates free radical tissue levels, serum cytokines, and neutrophil infiltration after severe liver ischemia [J].
GarciaCriado, FJ ;
PalmaVargas, JM ;
ValduncielGarcia, JJ ;
Toledo, AH ;
Misawa, K ;
GomezAlonso, A ;
ToledoPereyra, LH .
TRANSPLANTATION, 1997, 64 (04) :594-598
[16]  
GIULIAN D, 1989, J NEUROSCI, V9, P4416
[17]   FK506 and the role of the immunophilin FKBP-52 in nerve regeneration [J].
Gold, BG .
DRUG METABOLISM REVIEWS, 1999, 31 (03) :649-663
[18]  
Hartl R, 1997, J CEREBR BLOOD F MET, V17, P1210
[19]   Molecular mechanisms of neuroprotective action of immuno suppress ants - facts and hypotheses [J].
Kaminska, B ;
Gaweda-Walerych, K ;
Zawadzka, M .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2004, 8 (01) :45-58
[20]   FK506 and Its Analogs - Therapeutic Potential for Neurological Disorders [J].
Klettner, Alexa ;
Herdegen, Thomas .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2003, 2 (03) :153-162